Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3)
The summary for the Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3): The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II). The goal of the CADET program is to accelerate the development of novel products for the treatment of lung diseases and sleep disordered breathing using strategies based on relevant pathobiologic processes. Whereas the prior funding opportunity, CADET I, provided the opportunity to explore and validate potential therapeutic targets, the current funding opportunity, CADET II, hereafter designated "CADET," will support preclinical research on therapeutic products for which the target has been validated. It is anticipated that CADET projects may vary substantially in their objectives and scope of research.
Federal Grant Title: | Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HL-14-001 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.838 |
CFDA Descriptions: | Lung Diseases Research |
Current Application Deadline: | Oct 17, 2013 |
Original Application Deadline: | Oct 17, 2013 |
Posted Date: | Jul 17, 2013 |
Creation Date: | Jul 17, 2013 |
Archive Date: | Nov 17, 2013 |
Total Program Funding: | $75,000,000 |
Maximum Federal Grant Award: | $1,000,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and D...
- • HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clin...
- • Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzhei...
- • Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Syst...
- • Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed)